Clinical Trials
-
What Is Breakthrough Therapy Designation? FDA’s Accelerated Path Explained
When the FDA grants a biotech company Breakthrough Therapy Designation for a drug, the market typically reacts immediately — and often positively. The designation is a signal from one of the world’s most respected regulatory agencies that a drug shows early evidence of substantial improvement over existing therapies for a serious condition. For investors in…